9 Meters Biopharma, Inc.

NMTRQ

US6544052086

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 09:46:16 2024-05-01 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

Mar. 25	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer

May 30, 2023 at 09:25 am EDT

9 Meters Biopharma, Inc. announced that the Board of Directors has accepted the resignation of John Temperato as Chief Executive Officer of the Company effective immediately.

Latest news about 9 Meters Biopharma, Inc.

North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	Nov. 28	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 26	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 06	CI
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 02	CI
North American Morning Briefing : Stock Futures -2-	23-09-22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	23-09-15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	23-09-08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	23-09-01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	23-08-25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	23-08-18	DJ
North American Morning Briefing : Stock Futures -2-	23-08-11	DJ
Illumina cuts annual profit forecast as biotech funding woes linger	23-08-09	RE
Illumina cuts annual profit forecast	23-08-09	RE
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	23-07-25	CI
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	23-07-21	CI
Drug developer 9 Meters Biopharma files for bankruptcy protection	23-07-18	RE
9 Meters Biopharma, Inc. Filed for Bankruptcy	23-07-17	CI
9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	23-05-30	MT
9 Meters Biopharma, Inc. Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome	23-05-30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	23-05-30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	23-05-30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	23-05-29	CI
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	23-05-18	MT

Chart 9 Meters Biopharma, Inc.

Duration

Period

More charts

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Sector

Investment Holding Companies

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Shell Companies

	1st Jan change	Capi.
9 METERS BIOPHARMA, INC.	0.00%	14
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+158.06%	6.83B
SCREAMING EAGLE ACQUISITION CORP.	+0.47%	1.01B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.89%	797M
ARES ACQUISITION CORPORATION II	+1.63%	664M
E7 GROUP	-1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+32.01%	592M

Shell Companies